Introduction {#sec1_1}
============

Eccrine porocarcinoma (EPC), first described by Pinkus and Mehregan in 1963 \[[@B1]\], is an uncommon sweat gland carcinoma and the malignant counterpart of eccrine poroma. Although some large case series of EPC have been published \[[@B2], [@B3], [@B4], [@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11]\], the biological behavior of this entity has not been fully elucidated. Accurate diagnosis, optimal treatment, and prognosis of EPC are still challenging due to the paucity of data concerning this condition. The aim of this study is to report the clinical and pathological features of EPC and to contribute to the body of information currently available to dermatologists.

Patients and Methods {#sec1_2}
====================

Between 2003 and 2013, 8 patients were diagnosed with EPC at the Department of Dermatology in the Hachioji Medical Center of Tokyo Medical University. The clinical characteristics of the neoplasm, such as color, shape, and size, were evaluated and recorded by expert dermatologists. Resected specimens were fixed with 10% buffered formalin, and paraffin-embedded histological sections were stained with hematoxylin-eosin (HE). In addition to the routine microscopic observation, the following histopathological prognostic factors described by Robson et al. \[[@B7]\] were evaluated in each specimen: (1) lymphovascular invasion; (2) depth of invasion measured from the granular layer or ulcerated surface of the neoplasm to the deepest site of invasion; (3) number of mitoses per 10 high-power fields (HPF) by ×40 objective and ×10 eye space, and (4) growth pattern of the neoplastic margin. Moreover, immunohistochemical examinations using CAM5.2 (BD Biosciences, San Jose, Calif., USA), epithelial membrane antigen (EMA; DakoCytomation, Glostrup, Denmark), and carcinoembryonic antigen (CEA; DakoCytomation) were performed.

Results {#sec1_3}
=======

Clinical Findings {#sec2_1}
-----------------

The preoperative clinical features of the 8 cases, 6 Japanese males and 2 Japanese females, are shown in table [1](#T1){ref-type="table"}. The mean age was 72.6 years (range: 47--98 years). Two of the lesions had developed on the head, and 1 each on the back, arm, forearm, buttock, thigh, and lower leg. The duration of the lesions ranged from 4 months to 5 years (mean: 3.5 years). The mean size of the primary lesion was 39 mm (range: 18--70 mm). All cases presented reddish nodules displaying an erosive or ulcerated surface, while 5 cases displayed a pedunculated appearance (fig. [1a, b](#F1){ref-type="fig"}). The results of the initial CT imaging demonstrated multiple metastatic lesions to the mediastinum lymph node, and distant metastases to the brain, liver, and lung in only 1 case with the primary lesion on the left arm.

Histopathological Findings {#sec2_2}
--------------------------

The histopathological and immunohistochemical features of the primary lesions are documented in table [2](#T2){ref-type="table"}. In all cases, the malignant neoplastic lesions extended from the epidermis to the dermis (fig. [2a](#F2){ref-type="fig"}), and were composed of large, basaloid and atypical neoplastic cells with hyperchromatic nuclei and some mitotic figures (fig. [2b](#F2){ref-type="fig"}). Duct-like structures with eosinophilic cuticular borders were detected in all of the cases (fig. [2a](#F2){ref-type="fig"}).

Previously described prognostic factors were evaluated as follows: vascular invasion was detected in 1 case deep within the lesion (fig. [2c](#F2){ref-type="fig"}). The depth of invasion ranged from 0.7 to 20.0 mm (mean: 8.2 mm). The number of mitoses per 10 HPF varied from 0.6 to 12.3 (mean: 4.1). The growth patterns of the neoplastic margin were classified into 2 groups: an 'infiltrative' growth pattern was seen in 5 cases (fig. [2d](#F2){ref-type="fig"}), while a 'pushing' pattern was seen in 3 cases (fig. [2e](#F2){ref-type="fig"}).

Immunohistochemical examinations revealed that EMA was positive in all 8 cases, and CAM5.2 was positive in 5 cases. CEA, mostly stained in the duct-like structures, was positive in 6 cases.

Treatment and Clinical Course {#sec2_3}
-----------------------------

The details of the treatment and clinical course from the follow-up observation are summarized in table [1](#T1){ref-type="table"}. Surgical resection was performed in all of the cases. None of the resected specimens presented malignant cells on the surgical margin. As adjuvant therapy, local radiation therapy was administered in 2 cases presenting a narrow vertical margin. Chemotherapy consisting of 6 courses of docetaxel treatment plus 3 courses of docetaxel and cisplatin were administrated to the patient suffering from multiple metastases.

Follow-up observation was conducted in all of the cases. The duration of the observation ranged from 1 month to 2 years (mean: 10.9 months). During the follow-up period, 7 out of the 8 cases, including the patient who received 50 Gy of radiation therapy, showed neither local recurrence nor metastasis. Among them, the oldest case (98 years old) died of heart failure 3 months after the resection. The case with multiple metastases was treated with 21 Gy of radiation therapy and chemotherapy as described above, but nevertheless failed to show a clinical response; the patient experienced local recurrence on the periphery of the skin graft (fig. [3a](#F3){ref-type="fig"}) and multiple bone metastases afterwards. Although the recurrent lesion was surgically resected again, the histopathology demonstrated intradermal proliferation of EPC cells (fig. [3b](#F3){ref-type="fig"}), and the patient succumbed to his condition 8 months after the resection.

Because the prognostic outcomes such as local recurrence, lymph node metastasis, and distant metastasis were seen in only 1 case, a statistical analysis of the patients' prognosis and clinical or histopathological variables could not be performed.

Discussion {#sec1_4}
==========

In previous publications, some authors described EPC as a biologically aggressive neoplasm with a high rate of recurrence and metastasis \[[@B2]\]. In contrast, the largest case series by Robson et al. \[[@B7]\] (69 EPC cases) reported that local recurrence, lymph node metastasis, and distant metastasis were confined to 17, 20, and 10% of the cases, respectively, and concluded that aggressive behavior may be the exception. Similarly, other authors reported indolent biological behavior in EPC \[[@B3], [@B5], [@B6], [@B8]\]. In the present case series, only 1 out of the 8 cases (12.5%) presented a number of unfavorable clinical events including local recurrence, lymph node metastases, distant metastases, and mortality, which appeared to be consistent with the above-mentioned reports.

Robson et al. \[[@B7]\] also suggested the 4 histopathological findings as prognostic factors in EPC patients. Lymphovascular invasion was related to death. A depth of invasion greater than 7 mm or more than 14 mitoses per 10 HPF were associated with death or lymph node involvement. The infiltrative growth pattern was predictive of local recurrence. In the present case series, 1 aggressive case (Case 4) displayed 3 of these prognostic factors. The remaining cases also displayed the depth of invasion (Cases 3, 6, and 7) and infiltrating growth pattern (Case 1, 6, 7, and 8) considered to be predictive of recurrence or metastasis, but nevertheless showed neither of these outcomes. These inconsistent prognostic results were also reported in a retrospective study by Shiohara et al. \[[@B9]\], who observed that the number of mitoses and depth of invasion were not important prognostic factors. However, it should be noted that the present case series treated a small number of cases with a short period of follow-up observation, facts which might be responsible for the inconsistency of the prognostic results.

Conclusion {#sec1_5}
==========

In this paper, we reported 8 Japanese cases of EPC. Only 1 case resulted in a local recurrence, lymph node metastases, distant metastases, and death. The prognosis of EPC may not be as dismal as previously believed; however, this entity occasionally shows aggressive behavior. In spite of the prognostic factors outlined in previous reports, an accurate prediction of the outcomes of EPC still poses a challenge for the dermatologist. Early detection and complete excision can minimize the mortality rate in EPC.

![Clinical photographs of EPC. **a** Pedunculated reddish nodule with erosive surface (Case 5). **b** Large, ulcerated nodule (Case 7).](cde-0005-0259-g01){#F1}

![Histopathology of the EPC cases. **a** EPC components extend from the epidermis to the dermis (Case 1; HE; ×40). **b** Atypical neoplastic cells with hyperchromatic nuclei and some mitotic figures were seen. Arrows indicate the duct-like structures with eosinophilic cuticular borders (Case 7; HE; ×400). **c** Vascular invasion was seen deep within the lesion (Case 4; HE; ×400). **d** 'Infiltrative' growth pattern (Case 4; HE; ×100). **e** 'Pushing' growth pattern (Case 5; HE; ×100).](cde-0005-0259-g02){#F2}

![Clinical and histopathological features illustrating the local recurrent lesion. **a** Clinical photograph of the subcutaneous induration on the periphery of the skin graft (arrow: Case 4). **b** Histopathology of the recurrent lesion demonstrated intradermal proliferation of EPC cells (Case 4; HE; ×20).](cde-0005-0259-g03){#F3}

###### 

Clinical findings, treatment, and clinical course

  Case   Clinical findings   Treatment   Clinical course                                                                                
  ------ ------------------- ----------- ----------------- ------ ---- ---- ---- ---- ------- ----------------------- ---- ---- ------- ---------------
  1      77                  F           right buttock     5      20   --   --   \+   --      --                      7    --   --      --
  2      83                  M           head              1      18   --   --   \+   --      --                      7    --   --      --
  3      79                  F           left lower leg    0.33   32   --   --   \+   --      --                      1    --   --      --
  4      50                  M           left arm          0.58   80   \+   \+   \+   21 Gy   docetaxel + cisplatin   8    \+   bones   EPC
  5      80                  M           head              1      35   --   --   \+   --      --                      8    --   --      --
  6      47                  M           right thigh       5      30   --   --   \+   50 Gy   --                      48   --   --      --
  7      98                  M           right forearm     5      70   --   --   \+   --      --                      3    --   --      heart failure
  8      67                  M           back              2      30   --   --   \+   --      --                      5    --   --      --

###### 

Histopathological and immunohistochemical findings

  Case   Atypical poroid cell   Duct formation   Intra-epidermal lesion   Poroma-like components   Vascular invasion   Depth of invasion, mm   Mitoses, n/10 HPF   Growth pattern   Immunohistochemistry        
  ------ ---------------------- ---------------- ------------------------ ------------------------ ------------------- ----------------------- ------------------- ---------------- ---------------------- ---- ----
  1      \+                     \+               \+                       --                       --                  2.2                     1.8                 infiltrative     --                     \+   \+
  2      \+                     \+               --                       --                       --                  5.7                     0.6                 pushing          \+                     \+   \+
  3      \+                     \+               --                       \+                       --                  9.3                     0.9                 pushing          --                     \+   \+
  4      \+                     \+               --                       --                       \+                  8.0                     12.3                infiltrative     \+                     \+   \+
  5      \+                     \+               --                       --                       --                  5.9                     4.4                 pushing          --                     \+   \+
  6      \+                     \+               --                       --                       --                  13.6                    1.3                 infiltrative     \+                     \+   \+
  7      \+                     \+               --                       --                       --                  20.0                    8.7                 infiltrative     \+                     \+   --
  8      \+                     \+               --                       \+                       --                  0.7                     2.8                 infiltrative     \+                     \+   --
